” Selling pharmaceuticals is an extremely competitive business and companies know that they need to put their best face forward. That face is usually a smiling drug representative whose job it is to teach your physician about the newest medicines being produced today.
In Canada the drug industry spends roughly $3 billion per year marketing its products, two-thirds of which goes towards the salaries of the sales reps who visit our physicians regularly, and the drug samples they use to enhance their one-on-one learning sessions. “
Doctors not informed of harmful effects of medicines during sales visits
Last month a study concerning the world of prescription drug information identified a new and potentially deadly hazard: the pharmaceutical sales rep visit. The study asked the question: When a drug sales rep has a private one-to-one conversation with a doctor, what kind of drug information does the physician actually receive? … The study found that in nearly 60 per cent of promotional visits, sales representatives failed to provide any information about common or serious side-effects of the promoted drug, and also failed to inform doctors about the types of patients who should not use the medicine…
” Here are six new Pharma marketing initiatives that are guaranteed to keep investor expectations high along with our insurance premiums. The secret? Recycling old and discredited drugs and marketing diseases to sell the few new ones. ‘
” There is good news and bad news about attention deficit/hyperactivity disorder (ADHD) — that is, if you’re a drug company. The bad news is the kid market has peaked out with 4.5 million U.S. children now carrying the label. The good news is adult ADHD is an emerging market. In fact, adult ADHD, with symptoms similar to pediatric ADHD such as impulsivity, distractibility and difficulty paying attention, following instructions and meeting deadlines, is the next big thing “.
Every 14 minutes, a person is killed by prescription drugs…
” Every 14 minutes, a person is killed by prescription drugs — and unlike most other causes of preventable death, which have been on the decline for years, medication-induced deaths are on the upswing across the US. According to a recent analysis conducted by the Los Angeles Times, drug-induced deaths have become so prevalent that their average yearly total now exceeds the number of deaths caused by traffic accidents “.
” It’s the Catch-22 of clinical trials: to protect pregnant women and children from the risks of untested drugs….we don’t test drugs adequately for them. In the last few decades, we’ve been more concerned about the harms of research than of inadequately tested treatments for everyone, in fact. But for “vulnerable populations,” like pregnant women and children, the default was to exclude them. And just in case any women might be, or might become, pregnant, it was often easier just to exclude us all from trials. “
The AllTrials transparency campaign says it is at a crossroads and is looking to take the next step into becoming a larger force against the restriction of clinical trial data by pharma. It continues: “There are many who hope that AllTrials will fizzle out and go away, as previous efforts have done – what happens next is up to all of us. We need your help to grow internationally, and to push for a decisive and permanent change.”
” Gueriguian testified that Eli Lilly knew as early as 1998 that Zyprexa increased the risk of developing diabetes, but did not issue warnings about those effects until 2007… ‘Simply put, it’s putting profit over the concern of the consumer‘, Gueriguian said “.
Around half of all clinical trials have not been published; some trials have not even been registered. If action is not taken urgently, information on what was done and what was found in trials could be lost forever, leading to bad treatment decisions, missed opportunities for good medicine, and trials being repeated unnecessarily.